Molecular epidemiology of hepatitis viruses in Indonesia
印度尼西亚肝炎病毒的分子流行病学
基本信息
- 批准号:10041196
- 负责人:
- 金额:$ 2.24万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for international Scientific Research
- 财政年份:1998
- 资助国家:日本
- 起止时间:1998 至 无数据
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Molecular epiciemiological analysis of various hepatitis viruses in Surabaya, Indonesia, was performed.1. Hepatitis B virus (HBV) : Phylogenetic analysis of HBV DNA sequences amplified by PCR from sera of BBs Ag-positive asymptomatic carriers and patients with liver disease revealed that all the HBV strains tested belong to genotype B.2. Hepatitis D virus (HDV) : The prevalence of anti-HDV antibodies among HBs Ag-positive individuals was <0.5% (0/200). No information was available on the genotype of HDV.3. Hepatitis C virus (HCV) : HCV RNA titers in the serum were itis C viruscompared among different HCV subtypes. HCV-ld, the unique Indonesian subtype, was shown to be associated with high titers of viremia as was HCV-lb, the subtype most commonly found in Japan and thought to be associated with severe liver damage. On the other hand, HCV-2a was, in general, shown to be associated with relatively low titers of viremia compared with HCV-lb and HCV-ld. However, some HCV-2a strains isolated from patients with liver cirrhosis were found to be associated with high titers of viremia.4. GB virus C (GBV-C) : The prevalence of GBV-C, a new hepatitis virus candidate, among anti-HCV-positive and anti-HCV-negative blood donors was 21.9% (16/73) and 2.7% (4/150), respectively. Also, the prevalence among patients with chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma and those on hemodialysis was 5.7% (3/57), 16.5% (13/79), 8.5% (6/71) and 21.7% (15/69), respectively. Phylogenetic analysis of GBV-C RNA sequences identified the presence of a novel subtype of GBV-C in Indonesia.5. TT virus (TTV) : The prevalence of TTV, another new hepatitis virus candidate, among patients with chronic hepatitis and liver cirrhosis and those on hemodialysis was 21.9% (14/64), 24.0%(18/75) and 32.8% (20/61), respectively.
对印度尼西亚泗水地区的各种肝炎病毒进行了分子流行病学分析。乙肝病毒:用聚合酶链式反应从BBS、Ag阳性无症状携带者和肝病患者的血清中扩增出HBVDNA序列的系统发育分析表明,所有检测的HBV株都属于B型。丁型肝炎病毒(HDV):抗-HDV抗体在HBs Ag阳性个体中的流行率为0.5%(0/200)。目前尚无关于HDV的基因分型的信息。丙型肝炎病毒:丙型肝炎病毒不同亚型间血清中丙型肝炎病毒RNA滴度的比较。与在日本最常见的被认为与严重肝脏损害有关的丙型肝炎病毒1b亚型一样,印尼特有的丙型肝炎病毒1d亚型被证明与高滴度的病毒血症有关。另一方面,一般来说,与丙型肝炎病毒1b和丙型肝炎病毒1d相比,丙型肝炎病毒2a与相对较低的病毒血症滴度有关。然而,从肝硬变患者中分离出的一些丙型肝炎病毒2a株被发现与高滴度的病毒有关。GB病毒C(GBV-C):新的候选肝炎病毒GBV-C在抗-丙型肝炎病毒阳性和阴性献血员中的感染率分别为21.9%(16/73)和2.7%(4/150)。慢性肝炎、肝硬变、肝细胞癌和血液透析患者的感染率分别为5.7%(3/57)、16.5%(13/79)、8.5%(6/71)和21.7%(15/69)。对GBV-C RNA序列的系统发育分析表明,印度尼西亚存在一种新的GBV-C亚型。TT病毒(TTV):慢性肝炎、肝硬变和血液透析患者中TTV的感染率分别为21.9%(14/)、24.0%(18/75)和32.8%(20/61)。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Nidom, C.A.: "Detection of hepatitis TT virus among patients on maintenence hemodialysis in Surabaya, Indonesia : A preliminary study." ICMR Annals. 印刷中.
Nidom,C.A.:“印度尼西亚泗水维持性血液透析患者中 TT 病毒的检测:一项初步研究,正在出版。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Sukugawa, Hiroshi: "Novel variats of Heaptitis Delta virus genotype II predominantes in an endemic area, Okinawa, Japan." J.Med.Virol.印刷中.
Sukukawa, Hiroshi:“日本冲绳流行区的 Delta 病毒基因型 II 的新变种正在出版。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Ishido, Satoshi: "Methods in Molecular Medicine" The Humana Press, Inc.(in press).
Ishido, Satoshi:“分子医学方法”Humana Press, Inc.(正在印刷中)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Ishido, Satoshi: "Complex formation of the nonstructural protein 3 of hepatitis C virus with the p53 tumor suppressor." FEBS Lett.438. 258-262 (1998)
Ishido, Satoshi:“丙型肝炎病毒非结构蛋白 3 与 p53 肿瘤抑制因子的复杂形成。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Song, Jian: "The NS5A protein of hepatitis C virus partially inhibits the antiviral activity of interferon." J.Gen.Virol.80 (4). 879-886 (1999)
宋健:“丙型肝炎病毒的NS5A蛋白部分抑制干扰素的抗病毒活性。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
HOTTA Hak其他文献
HOTTA Hak的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('HOTTA Hak', 18)}}的其他基金
Study on molecular mechanisms of glucose metabolic disorders mediated by hepatitis C virus
丙型肝炎病毒介导的糖代谢紊乱的分子机制研究
- 批准号:
24590976 - 财政年份:2012
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Study on possible correlation between carcinogenic risk and genetic variation of hepatitis B and C viruses in Indonesia.
印度尼西亚乙型和丙型肝炎病毒致癌风险与遗传变异之间可能相关性的研究。
- 批准号:
16406015 - 财政年份:2004
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Viral factors that determine viremia titers of hepatitis C virus in Indonesia
决定印度尼西亚丙型肝炎病毒病毒血症滴度的病毒因素
- 批准号:
13576015 - 财政年份:2001
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Molecular epidemiology of hepatitis viruses in Indonesia
印度尼西亚肝炎病毒的分子流行病学
- 批准号:
11691209 - 财政年份:1999
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Scientific Research (B).
Inhibition of apoptosis by the NS3 protein of hepatitis C virus and its interaction with the p53 tumor suppressor protein.
丙型肝炎病毒 NS3 蛋白对细胞凋亡的抑制及其与 p53 肿瘤抑制蛋白的相互作用。
- 批准号:
09670317 - 财政年份:1997
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Study on hepatitis C virus new genotypes in Southeast Asia
东南亚丙型肝炎病毒新基因型研究
- 批准号:
08041176 - 财政年份:1996
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for international Scientific Research
相似海外基金
The 13th Canadian Symposium on Hepatitis C Virus (CSHCV)
第13届加拿大丙型肝炎病毒研讨会(CSHCV)
- 批准号:
487828 - 财政年份:2023
- 资助金额:
$ 2.24万 - 项目类别:
Miscellaneous Programs
Characterization of key aspects of a controlled human infection model (CHIM) for hepatitis C virus (HCV) infection
丙型肝炎病毒 (HCV) 感染受控人类感染模型 (CHIM) 关键方面的表征
- 批准号:
478700 - 财政年份:2023
- 资助金额:
$ 2.24万 - 项目类别:
Operating Grants
After the Cure: Measuring the full impacts of direct-acting antivirals for people living with HIV/hepatitis C virus coinfection in Canada
治愈之后:衡量直接作用抗病毒药物对加拿大艾滋病毒/丙型肝炎病毒合并感染者的全面影响
- 批准号:
469805 - 财政年份:2022
- 资助金额:
$ 2.24万 - 项目类别:
Operating Grants
Perinatal care as a venue to reduce opioid overdoses and hepatitis C virus incidence (PreVenT OD HCV)
围产期护理是减少阿片类药物过量和丙型肝炎病毒发病率 (PreVenT OD HCV) 的场所
- 批准号:
10449670 - 财政年份:2022
- 资助金额:
$ 2.24万 - 项目类别:
A Simple at-home test for rapid and accurate screening for Hepatitis C Virus (HCV) exposure
简单的家庭测试,可快速、准确地筛查丙型肝炎病毒 (HCV) 暴露
- 批准号:
10709130 - 财政年份:2022
- 资助金额:
$ 2.24万 - 项目类别:
Workshop for the development of a Controlled Human Infection Model (CHIM) for hepatitis C virus (HCV) infection
丙型肝炎病毒(HCV)感染的受控人类感染模型(CHIM)开发研讨会
- 批准号:
460792 - 财政年份:2022
- 资助金额:
$ 2.24万 - 项目类别:
Miscellaneous Programs
Rapid, Point-of-Care Diagnostics for Hepatitis C Virus
丙型肝炎病毒的快速护理点诊断
- 批准号:
10683045 - 财政年份:2022
- 资助金额:
$ 2.24万 - 项目类别:
Perinatal care as a venue to reduce opioid overdoses and hepatitis C virus incidence (PreVenT OD HCV)
围产期护理是减少阿片类药物过量和丙型肝炎病毒发病率 (PreVenT OD HCV) 的场所
- 批准号:
10620846 - 财政年份:2022
- 资助金额:
$ 2.24万 - 项目类别:
A Randomized Controlled Trial of Prophylaxis with Direct-acting Antivirals for Kidney Transplantation from Hepatitis C virus-infected donor to Uninfected Recipients (PREVENT-HCV)
直接作用抗病毒药物预防丙型肝炎病毒感染供者肾移植至未感染受者的随机对照试验 (PREVENT-HCV)
- 批准号:
10597168 - 财政年份:2022
- 资助金额:
$ 2.24万 - 项目类别:
Characterization of key aspects of a controlled human infection model (CHIM) for hepatitis C virus (HCV) infection
丙型肝炎病毒 (HCV) 感染受控人类感染模型 (CHIM) 关键方面的表征
- 批准号:
472508 - 财政年份:2022
- 资助金额:
$ 2.24万 - 项目类别:
Operating Grants














{{item.name}}会员




